PFA
BSX icon

Pure Financial Advisors’s Boston Scientific BSX Stock Holding History

Pure Financial Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Buy
+5,234
New +$284K ﹤0.01% 577
2024
Q2 		– Sell
-3,571
Closed -$245K – 314
2024
Q1 		$245K Buy
+3,571
New +$230K 0.01% 276

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pure Financial Advisors's BSX Position: Q2 2026 in Review

Pure Financial Advisors opened a new position in Boston Scientific (BSX) in Q2 2026: 5,234 shares worth $223K. The stake represents ﹤0.01% of the portfolio and ranks #577 among its holdings. This is a return to the name: Pure Financial Advisors previously reported a position in BSX as recently as Q1 2024.

Pure Financial Advisors first reported a position in BSX in Q1 2024 and has held it in 2 quarters since. The position peaked at $245K in Q1 2024. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Pure Financial Advisors held 5,234 shares of Boston Scientific worth $223K as of Q2 2026.
  • Boston Scientific was a new Pure Financial Advisors position in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Pure Financial Advisors's portfolio in Q2 2026, its #577 holding.
  • Pure Financial Advisors first reported a position in Boston Scientific in Q1 2024 and has held it in 2 quarters since.
  • Pure Financial Advisors's Boston Scientific position peaked at $245K in Q1 2024.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Pure Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.